The emerging treatment of the medication represents a significant breakthrough in the handling of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets two pathways – GLP-1 and the GIP hormone https://tirzepatide-peptide311608.aboutyoublog.com/54525041/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment